Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography

Atherosclerosis

Volumn 241, Issue 1, 2014, Pages 234-240

  Gijsberts, Crystel M ^a,b   Gohar, Aisha ^a   Ellenbroek, Guilielmus H J M ^a   Hoefer, Imo E ^a   de Kleijn, Dominique P V ^a,b,d,e   Asselbergs, Folkert W ^a,b,c   Nathoe, Hendrik M ^a   Agostoni, Pierfrancesco ^a   Rittersma, Saskia Z H ^a   Pasterkamp, Gerard ^a   Appelman, Yolande ^f   den Ruijter, Hester M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarkers; Coronary angiography; Epidemiology; Sex

Indexed keywords

BIOLOGICAL MARKER;

AGED; BIOBANK; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEALTH DISPARITY; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PREDICTIVE VALUE; PROGNOSIS; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL MODEL;

AGED; BIOLOGICAL SPECIMEN BANKS; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84955375999     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.002     Document Type: Article

References (41)

1. Alwan A. Global Status Report on Noncommunicable Diseases 2010 2011, Switzerland, Geneva. first ed.
2. Vivona N., Bivona G., Noto D., Sasso B.Lo, Cefalù A.B., Chiarello G., et al. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. Clin. Biochem. 2009, 42:1713-1718.
3. Abdullah S.M., Khera A., Das S.R., Stanek H.G., Canham R.M., Chung A.K., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am. J. Cardiol. 2005, 96:1284-1289.
4. Goyal B.M., Sharma S.M., Walia M. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function. Indian Heart J. 2014, 66:183-187.
5. Kurtul A., Yarlioglues M., Murat S.N., Duran M., Acikgoz S.K., Sensoy B., et al. N-terminal pro-brain natriuretic peptide level is associated with severity and complexity of coronary atherosclerosis in patients with acute coronary syndrome. Clin. Appl. Thromb. Hemost. 2014 Jul 2, pii: 1076029614541954. [Epub ahead of print].
6. Wensley F., Gao P., Burgess S., Kaptoge S., Di Angelantonio E., Shah T., et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011, 342:d548.
7. Arroyo-Espliguero R., Avanzas P., Quiles J., Kaski J.C. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2009, 204:239-243.
8. Dandana A., Gammoudi I., Chalghoum A., Chahed H., Addad F., Ferchichi S., et al. Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease. J. Clin. Lab. Anal. 2014, 28:191-197.
9. Imai A., Komatsu S., Ohara T., Kamata T., Yoshida J., Miyaji K., et al. Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography. Atherosclerosis 2011, 218:350-355.
10. Koc M., Batur M.K., Karaarslan O., Abali G. Clinical utility of serum cystatin C in predicting coronary artery disease. Cardiol. J. 2010, 17:374-380.
11. Luc G., Bard J.-M., Lesueur C., Arveiler D., Evans A., Amouyel P., et al. Plasma cystatin-C and development of coronary heart disease: the PRIME Study. Atherosclerosis 2006, 185:375-380.
12. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., Maseri A. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 2002, 347:5-12.
13. Wainstein R.V., Wainstein M.V., Ribeiro J.P., Dornelles L.V., Tozzati P., Ashton-Prolla P., et al. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease. Clin. Biochem. 2010, 43:57-62.
14. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münzel T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
15. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
16. Ndrepepa G., Braun S., Schulz S., Mehilli J., Schömig A., Kastrati A. High-sensitivity troponin T level and angiographic severity of coronary artery disease. Am. J. Cardiol. 2011, 108:639-643.
17. Laufer E.M., Mingels A.M., Winkens M.H., Joosen I.A., Schellings M.W., Leiner T., et al. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1269-1275.
18. Van Loon J.E., Kavousi M., Leebeek F.W.G., Felix J.F., Hofman A., Witteman J.C.M., et al. von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population. J. Thromb. Haemost. 2012, 10:1262-1269.
19. Melloni C., Berger J.S., Wang T.Y., Gunes F., Stebbins A., Pieper K.S., et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ. Cardiovasc. Qual. Outcomes 2010, 3:135-142.
20. Hellings W.E., Pasterkamp G., Verhoeven B.A.N., De Kleijn D.P.V., De Vries J.-P.P.M., Seldenrijk K.A., et al. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J. Vasc. Surg. 2007, 45:289-296. (discussion 296-7).
21. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 2006, 47:C13-C18.
22. Sianos G., Morel M., Kappetein A.P., Morice M., Colombo A., Dawkins K., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
23. Serruys P.W., Onuma Y., Garg S., Sarno G., van den Brand M., Kappetein A.-P., et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009, 5:50-56.
24. Généreux P., Palmerini T., Caixeta A., Cristea E., Mehran R., Sanchez R., et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ. Cardiovasc. Interv. 2011, 4:553-561.
25. R Core Team R: a language and environment for statistical computing. R Foundation for Statistical Computing 2013, Austria, Vienna.
26. Smilowitz N.R., Sampson B.A., Abrecht C.R., Siegfried J.S., Hochman J.S., Reynolds H.R. Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. Am. Heart J. 2011, 161:681-688.
27. Han S.H., Bae J.H., Holmes D.R., Lennon R.J., Eeckhout E., Barsness G.W., et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur. Heart J. 2008, 29:1359-1369.
28. Khaki A.A., Khaki A., Heydari M., Gholizadeh L. A description of gender differences in angiographic findings in a single-center Iranian hospital. J. Vasc. Nurs. 2010, 28:11-13.
29. Vrijenhoek J.E.P., Den Ruijter H.M., De Borst G.J., de Kleijn D.P.V., De Vries J.-P.P.M., Bots M.L., et al. Sex is associated with the presence of atherosclerotic plaque hemorrhage and modifies the relation between plaque hemorrhage and cardiovascular outcome. Stroke 2013, 44:3318-3323.
30. Calabrò P., Golia E., Yeh E.T.H. CRP and the risk of atherosclerotic events. Semin. Immunopathol. 2009, 31:79-94.
31. Ndrepepa G., Braun S., Cassese S., Fusaro M., King L., Kastrati A., et al. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovasc. Revasc. Med. 2013, 14:264-269.
32. Garcia-Moll X., Zouridakis E., Cole D., Kaski J.C. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur. Heart J. 2000, 21:1598-1606.
33. Patel D., Jhamnani S., Ahmad S., Silverman A., Lindsay J. Discordant association of C-reactive protein with clinical events and coronary luminal narrowing in postmenopausal women: data from the Women's Angiographic Vitamin and Estrogen (WAVE) study. Clin. Cardiol. 2013, 36:535-541.
34. Ong P., Athanasiadis A., Borgulya G., Mahrholdt H., Kaski J.C., Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries. J. Am. Coll. Cardiol. 2012, 59:655-662.
35. Ong P., Carro A., Athanasiadis A., Borgulya G., Schäufele T., Ratge D., et al. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein. Coron. Artery Dis. 2014, 1-7.
36. Recio-Mayoral A., Mason J.C., Kaski J.C., Rubens M.B., Harari O.A., Camici P.G. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur. Heart J. 2009, 30:1837-1843.
37. Recio-Mayoral A., Rimoldi O.E., Camici P.G., Kaski J.C. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc. Imaging 2013, 6:660-667.
38. Lønnebakken M.T., Nordrehaug J.E., Gerdts E. No gender difference in the extent of myocardial ischemia in non-ST elevation myocardial infarction. Eur. J. Prev. Cardiol. 2014, 21:123-129.
39. Bugiardini R., Manfrini O., De Ferrari G.M. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch. Intern. Med. 2006, 166:1391-1395.
40. Gulati M., Cooper-DeHoff R.M., McClure C., Johnson B.D., Shaw L.J., Handberg E.M., et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch. Intern. Med. 2009, 169:843-850.
41. Radico F., Cicchitti V., Zimarino M., De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc. Interv. 2014, 7:453-463.